Art

J-GLOBAL ID：202102265661435560   Reference number：21A0828275

The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma

肝細胞癌におけるアンジオポエチン/Tie2経路【JST・京大機械翻訳】

Author (6)： Vanderborght Bart (Department of Internal Medicine and Pediatrics, Department of Gastroenterology and Hepatology, Hepatology Research Unit, Ghent University, B-9000 Ghent, Belgium) ,  Vanderborght Bart (Department of Basic and Applied Medical Sciences, Gut-Liver Immunopharmacology Unit, Ghent University, B-9000 Ghent, Belgium) ,  Lefere Sander (Department of Internal Medicine and Pediatrics, Department of Gastroenterology and Hepatology, Hepatology Research Unit, Ghent University, B-9000 Ghent, Belgium) ,  Lefere Sander (Department of Basic and Applied Medical Sciences, Gut-Liver Immunopharmacology Unit, Ghent University, B-9000 Ghent, Belgium) ,  Vlierberghe Hans Van (Department of Internal Medicine and Pediatrics, Department of Gastroenterology and Hepatology, Hepatology Research Unit, Ghent University, B-9000 Ghent, Belgium) ,  Devisscher Lindsey (Department of Basic and Applied Medical Sciences, Gut-Liver Immunopharmacology Unit, Ghent University, B-9000 Ghent, Belgium)
Material： Cells (Web)
Volume： 9  Issue： 11  Page： 2382  Publication year： 2020 
JST Material Number： U7155A  ISSN： 2073-4409  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Due to the usually late diagno...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0828275&from=J-GLOBAL&jstjournalNo=U7155A") }}

Thesaurus term： antitumor action ,  prognosis ,  targeting ,  *hepatoma ,  cellular signal transduction ,  angiogenesis ,  biomarker ,  VEGF
Semi thesaurus term： 疾患進行 ,  *TIE-2受容体 ,  *アンギオポイエチン ,  健康問題 ,  予測因子 ,  全身療法 , 【Automatic Indexing@JST】

Author keywords (9)： angiopoietin-1 ,  angiopoietin-2 ,  hepatocellular carcinoma ,  angiogenesis ,  vascular endothelial growth factor ,  treatment ,  biomarker ,  diagnosis ,  prognosis

JST classification (1)： Tumors(=neoplasms)of digestive system  (GH04000D)

Reference (82)：

• Rawla, P.; Sunkara, T.; Muralidharan, P.; Raj, J.P. Update in global trends and aetiology of hepatocellular carcinoma. Contemp. Oncol. (Pozn.) 2018, 22, 141-150.
• Davis, G.L.; Dempster, J.; Meler, J.D.; Orr, D.W.; Walberg, M.W.; Brown, B.; Berger, B.D.; O’Connor, J.K.; Goldstein, R.M. Hepatocellular carcinoma: Management of an increasingly common problem. Proc. (Bayl. Univ. Med. Cent.) 2008, 21, 266-280.
• Setiawan, V.W.; Stram, D.O.; Porcel, J.; Lu, S.C.; Le Marchand, L.; Noureddin, M. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort. Hepatology 2016, 64, 1969-1977.
• Yang, J.D.; Hainaut, P.; Gores, G.J.; Amadou, A.; Plymoth, A.; Roberts, L.R. A global view of hepatocellular carcinoma: Trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 2019, 16, 589-604.
• Ghouri, Y.A.; Mian, I.; Rowe, J.H. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. J. Carcinog. 2017, 16, 1.

Terms in the title (4)： 肝細胞癌 ,  アンジオポエチン ,  Tie2 ,  経路